AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of ARS 377.20 trillion. The enterprise value is 450.11 trillion.

Market Cap	377.20T
Enterprise Value	450.11T

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	Apr 15, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 84.60 and the forward PE ratio is 14.90.

PE Ratio	84.60
Forward PE	14.90
PS Ratio	6.13
PB Ratio	240.43
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.46, with an EV/FCF ratio of 27.26.

EV / Earnings	100.95
EV / Sales	6.98
EV / EBITDA	14.46
EV / EBIT	21.07
EV / FCF	27.26

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 47.90.

Current Ratio	0.76
Quick Ratio	0.48
Debt / Equity	47.90
Debt / EBITDA	2.53
Debt / FCF	4.55
Interest Coverage	6.68

Financial Efficiency

Return on equity (ROE) is 88.40% and return on invested capital (ROIC) is 15.45%.

Return on Equity (ROE)	88.40%
Return on Assets (ROA)	8.34%
Return on Invested Capital (ROIC)	15.45%
Return on Capital Employed (ROCE)	19.06%
Revenue Per Employee	1.12B
Profits Per Employee	81.07M
Employee Count	55,000
Asset Turnover	0.40
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+27.17%
50-Day Moving Average	24,454.00
200-Day Moving Average	22,957.38
Relative Strength Index (RSI)	44.51
Average Volume (20 Days)	1,229

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.55

Income Statement

In the last 12 months, AbbVie had revenue of ARS 61.56 trillion and earned 4.46 trillion in profits. Earnings per share was 2,510.97.

Revenue	61.56T
Gross Profit	43.72T
Operating Income	20.40T
Pretax Income	3.89T
Net Income	4.46T
EBITDA	29.37T
EBIT	20.40T
Earnings Per Share (EPS)	2,510.97

Full Income Statement

Balance Sheet

The company has 5.55 trillion in cash and 75.14 trillion in debt, giving a net cash position of -69,588.39 billion.

Cash & Cash Equivalents	5.55T
Total Debt	75.14T
Net Cash	-69,588.39B
Net Cash Per Share	n/a
Equity (Book Value)	1.57T
Book Value Per Share	862.71
Working Capital	-9,366.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.60 trillion and capital expenditures -1,090.27 billion, giving a free cash flow of 16.51 trillion.

Operating Cash Flow	17.60T
Capital Expenditures	-1,090.27B
Free Cash Flow	16.51T
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 33.15% and 7.31%.

Gross Margin	71.01%
Operating Margin	33.15%
Pretax Margin	6.31%
Profit Margin	7.31%
EBITDA Margin	47.70%
EBIT Margin	33.15%
FCF Margin	26.82%

Dividends & Yields

This stock pays an annual dividend of 488.77, which amounts to a dividend yield of 2.22%.

Dividend Per Share	488.77
Dividend Yield	2.22%
Dividend Growth (YoY)	102.60%
Years of Dividend Growth	4
Payout Ratio	266.46%
Buyback Yield	-0.03%
Shareholder Yield	2.20%
Earnings Yield	1.18%
FCF Yield	4.38%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	n/a